StockWatch
·
Pharmaceuticals
Board Meeting5 Nov 2026, 01:19 pm

Kwality Pharmaceuticals Board Meeting on Nov 12, 2026

AI Summary

Kwality Pharmaceuticals Ltd has announced a Board of Directors meeting scheduled for November 12, 2026. The primary agenda is to consider and approve the Unaudited Standalone and Consolidated Financial Results for the quarter and half-year ended September 30, 2026. The trading window for designated persons will remain closed until 48 hours after the declaration of these financial results.

Key Highlights

  • Board meeting scheduled for November 12, 2026.
  • To approve Unaudited Standalone and Consolidated Financial Results.
  • Financial period ending September 30, 2026.
  • Trading window closure extended post-results announcement.